AbbVie Inc. (BIT:1ABBV)
Italy
· Delayed Price · Currency is EUR 200.50
0.00 (0.00%)
Last updated: Mar 5, 2026, 9:00 AM CET
AbbVie Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 61,160 | 56,334 | 54,318 | 58,054 | 56,197 | Upgrade
|
| Revenue Growth (YoY) | 8.57% | 3.71% | -6.44% | 3.30% | 22.69% | Upgrade
|
| Cost of Revenue | 17,357 | 16,689 | 16,826 | 16,527 | 17,314 | Upgrade
|
| Gross Profit | 43,803 | 39,645 | 37,492 | 41,527 | 38,883 | Upgrade
|
| Selling, General & Admin | 13,644 | 14,099 | 12,419 | 14,584 | 11,872 | Upgrade
|
| Research & Development | 9,068 | 8,131 | 7,038 | 6,487 | 6,820 | Upgrade
|
| Other Operating Expenses | -24 | -7 | -179 | 228 | 432 | Upgrade
|
| Operating Expenses | 22,688 | 22,223 | 19,278 | 21,299 | 19,124 | Upgrade
|
| Operating Income | 21,115 | 17,422 | 18,214 | 20,228 | 19,759 | Upgrade
|
| Interest Expense | -2,893 | -2,808 | -2,224 | -2,230 | -2,423 | Upgrade
|
| Interest & Investment Income | 266 | 648 | 540 | 186 | 39 | Upgrade
|
| Currency Exchange Gain (Loss) | -58 | -21 | -146 | -148 | -51 | Upgrade
|
| Other Non Operating Income (Expenses) | 403 | 271 | 190 | 142 | 55 | Upgrade
|
| EBT Excluding Unusual Items | 18,833 | 15,512 | 16,574 | 18,178 | 17,379 | Upgrade
|
| Merger & Restructuring Charges | -95 | -792 | -288 | -539 | -587 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 172 | - | Upgrade
|
| Asset Writedown | -847 | -4,476 | -4,130 | -876 | - | Upgrade
|
| Other Unusual Items | -6,278 | -3,771 | -5,128 | -2,761 | -2,679 | Upgrade
|
| Pretax Income | 6,597 | 3,716 | 6,250 | 13,477 | 12,989 | Upgrade
|
| Income Tax Expense | 2,364 | -570 | 1,377 | 1,632 | 1,440 | Upgrade
|
| Earnings From Continuing Operations | 4,233 | 4,286 | 4,873 | 11,845 | 11,549 | Upgrade
|
| Minority Interest in Earnings | -7 | -8 | -10 | -9 | -7 | Upgrade
|
| Net Income | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 | Upgrade
|
| Preferred Dividends & Other Adjustments | 40 | 40 | 43 | 54 | 74 | Upgrade
|
| Net Income to Common | 4,186 | 4,238 | 4,820 | 11,782 | 11,468 | Upgrade
|
| Net Income Growth | -1.22% | -12.03% | -58.91% | 2.55% | 150.04% | Upgrade
|
| Shares Outstanding (Basic) | 1,769 | 1,769 | 1,768 | 1,771 | 1,770 | Upgrade
|
| Shares Outstanding (Diluted) | 1,773 | 1,773 | 1,773 | 1,778 | 1,777 | Upgrade
|
| Shares Change (YoY) | - | - | -0.28% | 0.06% | 6.22% | Upgrade
|
| EPS (Basic) | 2.37 | 2.40 | 2.73 | 6.65 | 6.48 | Upgrade
|
| EPS (Diluted) | 2.36 | 2.39 | 2.72 | 6.63 | 6.45 | Upgrade
|
| EPS Growth | -1.26% | -12.13% | -58.97% | 2.79% | 137.13% | Upgrade
|
| Free Cash Flow | 17,816 | 17,832 | 22,062 | 24,248 | 21,990 | Upgrade
|
| Free Cash Flow Per Share | 10.05 | 10.06 | 12.44 | 13.64 | 12.38 | Upgrade
|
| Dividend Per Share | 6.650 | 6.290 | 5.990 | 5.710 | 5.310 | Upgrade
|
| Dividend Growth | 5.72% | 5.01% | 4.90% | 7.53% | 9.71% | Upgrade
|
| Gross Margin | 71.62% | 70.38% | 69.02% | 71.53% | 69.19% | Upgrade
|
| Operating Margin | 34.52% | 30.93% | 33.53% | 34.84% | 35.16% | Upgrade
|
| Profit Margin | 6.84% | 7.52% | 8.87% | 20.29% | 20.41% | Upgrade
|
| Free Cash Flow Margin | 29.13% | 31.65% | 40.62% | 41.77% | 39.13% | Upgrade
|
| EBITDA | 29,254 | 25,808 | 26,912 | 28,695 | 28,280 | Upgrade
|
| EBITDA Margin | 47.83% | 45.81% | 49.55% | 49.43% | 50.32% | Upgrade
|
| D&A For EBITDA | 8,139 | 8,386 | 8,698 | 8,467 | 8,521 | Upgrade
|
| EBIT | 21,115 | 17,422 | 18,214 | 20,228 | 19,759 | Upgrade
|
| EBIT Margin | 34.52% | 30.93% | 33.53% | 34.84% | 35.16% | Upgrade
|
| Effective Tax Rate | 35.83% | - | 22.03% | 12.11% | 11.09% | Upgrade
|
| Advertising Expenses | 2,100 | 2,100 | 2,200 | 2,000 | 2,100 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.